Tislelizumab Combined With Chemotherapy in First-line Treatment of AGC
Conditions: Tislelizumab; Chemotherapy; First-line; Gastric Cancer Stage IV Intervention: Drug: Tislelizumab Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Academies | Cancer | Cancer & Oncology | Chemotherapy | China Health | Gastroenterology | Hospitals | Research